Eissler, N., Sveinbjörnsson, B., Kock, A., Johnsen, J. I., & Kogner, P. (2014). Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy. J Immunother Cancer.
Citação norma ChicagoEissler, Nina, Baldur Sveinbjörnsson, Anna Kock, John Inge Johnsen, and Per Kogner. "Immune Suppression By Myeloid-derived Suppressor Cells, MDSCs, in MYCN-driven Neuroblastoma Provides a Potential Target for Cancer Immunotherapy." J Immunother Cancer 2014.
MLA citiranjeEissler, Nina, et al. "Immune Suppression By Myeloid-derived Suppressor Cells, MDSCs, in MYCN-driven Neuroblastoma Provides a Potential Target for Cancer Immunotherapy." J Immunother Cancer 2014.
Opozorilo: Ti citati niso vedno 100% točni.